Santen Pharmaceutical
Venture capital · Emeryville, California, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
3Deep-tech portfolio1 active
2Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Aldeyra Therapeutics
4Co-investorsShare a portfolio company
Portfolio · 3 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Eyevance Pharmaceuticals | Biotech | Active | — | — |
| Aldeyra Therapeutics | Biotech | Public | Feb 11, 2019 | $24.6M |
| Shire Pharmaceuticals | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#136
Portfolio exits#103
Raises, 12 months#88
Co-investors#209
Co-investors
- Domain AssociatesVenture capital1 shared
- MPM BioImpactVenture capital1 shared
- MPM CapitalVenture capital1 shared
- Oxford Bioscience PartnersVenture capital1 shared
Sectors
- Biotech3
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.